Today: 21 May 2026
Browse Category

NASDAQ:MIGI 16 October 2025 - 12 December 2025

Mawson Infrastructure Group (MIGI) Stock in 2025: Reverse Split, AI Pivot and High Volatility Explained

Mawson Infrastructure Group (MIGI) Stock in 2025: Reverse Split, AI Pivot and High Volatility Explained

Mawson Infrastructure Group posted its first profitable quarter in years, reporting $0.3 million net income for Q3 2025 after a $12.2 million loss a year earlier. Shares plunged over 40% after a 1-for-20 reverse split, then rebounded before a December 11 investor presentation. Year-to-date revenue fell 17%, but operating losses narrowed sharply.
11 December 2025
···
Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Mawson Infrastructure (NASDAQ: MIGI) shares surged 13.36% to $1.00 on Oct. 14 and traded near $1.28 by mid-morning Oct. 15, doubling over two weeks amid crypto market swings. The company recently fired CEO Rahul Mewawalla for cause during a fraud lawsuit and secured a Nasdaq compliance extension. Interim CEO Kaliste Saloom now leads. Analysts remain cautious as volatility continues.
16 October 2025
···

Stock Market Today

  • Aris Mining Q1 Earnings Surge Amid Stock Decline
    May 20, 2026, 7:24 PM EDT. Aris Mining (TSX:ARIS) reported a strong Q1 2026 with sales of US$372.48 million and net income of US$97.61 million, boosting basic earnings per share to US$0.47 from US$0.01 last year. Despite robust profitability, the stock dropped 10.9% due to execution risks in Marmato and Segovia expansion projects that could impact future cash flow. The Marmato underground cross cut progress supports the planned Q4 2026 gold production. Analysts remain divided, projecting revenues between US$2.4 billion to US$2.6 billion and earnings up to US$1.3 billion by 2028-2029. With a fair value estimate of CA$40.75 implying a 69% upside, investors weigh growth potential against operational and financing uncertainties. The stock's performance reflects the market's cautious stance amid a promising but risk-laden outlook.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop